Standard
No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjects. / Nauck, M. A.; Holle, H.; Kahle, M.; Tytko, A.; Deacon, C. F.; Holst, J. J.; Meier, J. J.
In:
Peptides, Vol. 125, 170176, 2020.
Research output: Contribution to journal › Review › Research › peer-review
Harvard
Nauck, MA, Holle, H, Kahle, M, Tytko, A
, Deacon, CF, Holst, JJ & Meier, JJ 2020, '
No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjects',
Peptides, vol. 125, 170176.
https://doi.org/10.1016/j.peptides.2019.170176APA
Nauck, M. A., Holle, H., Kahle, M., Tytko, A.
, Deacon, C. F., Holst, J. J., & Meier, J. J. (2020).
No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjects.
Peptides,
125, [170176].
https://doi.org/10.1016/j.peptides.2019.170176Vancouver
Nauck MA, Holle H, Kahle M, Tytko A
, Deacon CF, Holst JJ et al.
No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjects.
Peptides. 2020;125. 170176.
https://doi.org/10.1016/j.peptides.2019.170176Author
Nauck, M. A. ; Holle, H. ; Kahle, M. ; Tytko, A. ; Deacon, C. F. ; Holst, J. J. ; Meier, J. J. / No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjects. In: Peptides. 2020 ; Vol. 125.
Bibtex
@article{2b85b9b1f1844680b09c19fbf7437419,
title = "No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjects",
keywords = "Gastric inhibitory polypeptide, Glucose-dependent insulinotropic peptide, Tachyphylaxis, Desensitization, Insulin secretion, Hyperglycaemic clamp",
author = "Nauck, {M. A.} and H. Holle and M. Kahle and A. Tytko and Deacon, {C. F.} and Holst, {J. J.} and Meier, {J. J.}",
year = "2020",
doi = "10.1016/j.peptides.2019.170176",
language = "English",
volume = "125",
journal = "Peptides",
issn = "0196-9781",
publisher = "Elsevier",
}
RIS
TY - JOUR
T1 - No evidence of tachyphylaxis for insulinotropic actions of glucose-dependent insulinotropic polypeptide (GIP) in subjects with type 2 diabetes, their first-degree relatives, or in healthy subjects
AU - Nauck, M. A.
AU - Holle, H.
AU - Kahle, M.
AU - Tytko, A.
AU - Deacon, C. F.
AU - Holst, J. J.
AU - Meier, J. J.
PY - 2020
Y1 - 2020
KW - Gastric inhibitory polypeptide
KW - Glucose-dependent insulinotropic peptide
KW - Tachyphylaxis
KW - Desensitization
KW - Insulin secretion
KW - Hyperglycaemic clamp
U2 - 10.1016/j.peptides.2019.170176
DO - 10.1016/j.peptides.2019.170176
M3 - Review
C2 - 31669136
VL - 125
JO - Peptides
JF - Peptides
SN - 0196-9781
M1 - 170176
ER -
